Last $2.99 USD
Change Today -0.15 / -4.78%
Volume 1.0M
RIGL On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Elliott B. Grossbard M.D.

Chief Medical Officer and Executive Vice President, Rigel Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Dr. Elliott B. Grossbard, MD, serves as the Chief Medical Officer and Executive Vice President of Rigel Pharmaceuticals, Inc. Dr. Grossbard served as Senior Vice President of Medical Development at Rigel Pharmaceuticals, Inc. since April 2002. Dr. Grossbard served as Vice President of Clinical Affairs for Avigen Inc. Dr. Grossbard served as a Senior Vice President of Development and Vice President of Medical & Regulatory Affairs at Scios, Inc. where, he oversaw several ...

Read Full Background

Corporate Headquarters*

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships*

Former Director


Unknown/Other Education
Columbia University
Columbia University
Yale Law School
Columbia College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$521,339

Stock Options*

All Other Compensation$9,906
Exercisable Options943,750
Unexercisable Options81,250
Total Number of Options1,025,000

Total Compensation*

Total Annual Cash Compensation$531,245
Total Short Term Compensation$521,339
Other Long Term Compensation$9,906
Total Calculated Compensation$1,201,145
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $2.99 USD -0.15


Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Myung-Joong Cho Ph.D.Founder, Chief Executive Officer and President
CrystalGenomics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at